Skip to main content

Recent Scientific Presentations

2011

  • Discovery of TAK-960: an Orally Available Small Molecule Inhibitor of Polo-Like Kinase 1 (Plk1)
    Zhe Nie
    242nd ACS National Meeting, August 28, 2011 Denver, CO
  • Developing an Analytical Methods Platform to Support ADCs - Finding the Optimal Antibody Drug Combination
    Mike Buckley
    World ADC Summit, February 21, 2011 Frankfurt, Germany
  • The Influence of Antigen, Antibody and ADC Properties in In Vitro and In Vivo Cytotoxicity
    Gregory Landes
    Antibody Drug Products Meeting at CHI PepTalk, January 10, 2011 San Diego, CA

2010

  • Development of New Chiral Chromatographic Methods for the Analysis and Purification of Pharmaceutical Samples
    Lu Zeng
    Chirality 2010, July 11 -15, 2010 Sapporo, Japan
  • Discovery of NesinaTM, a Potent DPP-4 Inhibitor for the Treatment of Diabetes Mellitus Type 2, using Structural Enzymology Approaches
    Kathleen Aertgeerts
    EMBO Conference Series: Catalytic Mechanisms by Biological Systems: at the interface between chemistry and biology, May 7, 2010 Hamburg, Germany
  • Fragment-based discovery of TAK-901, a novel multi-targeted Aurora B kinase inhibitor
    Ron de Jong
    101st AACR Annual Meeting, April 17-21, 2010 Washington, DC
  • Antibody Target Discovery
    Mary Haak-Frendscho
    4 Annual Proteins Congress, April 4th, 2010 London, England